Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
120 participants
INTERVENTIONAL
2006-04-13
2008-11-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Auricular Acupressure Versus Intermittent Dietary Restriction in Children With Gastric Heat and Dampness Obstruction
NCT05847478
Parent-Based Treatment for Pediatric Overweight
NCT00807560
Pilot Data Collection for Activity, Adiposity, and Appetite in Adolescents
NCT03157063
Postprandial Thermogenesis in Obese Adolescents: Effect of Meal Calorie Content
NCT07233174
Energy Expenditure Methodology Infant
NCT01905085
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
TREATMENT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Non-Exercise Activity Thermogenesis (NEAT)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Good general health. Individuals taking medications for any serious medical condition will be excluded.
2. Age 7 to 11 years.
3. Body Mass Index 15th to 85th percentile for lean children or greater than or equal to 95% for age for overweight children.
4. Pre-pubertal (breast Tanner I - III for girls, testes size less than or equal to 10 mL for boys).
Exclusion Criteria
1. Presence of major illnesses: renal, hepatic, gastrointestinal, most endocrinologic (e.g., Cushing syndrome, untreated hyper- or hypothyroidism), hematological problems or pulmonary disorders.
2. Taking any medications that might interfere with weight or growth such as oral steroids, or psychotropic agents.
3. Presence of movement or tic disorders, since conditions increasing involuntary movements may interfere with the measurement of NEAT.
4. Individuals who are taking and/or have taken stimulant or weight loss medications in the last 6 months.
5. Individuals who cannot commit to living in a similar environment with similar levels of activity during the two weeks they wear the activity monitors and timer (i.e. cannot have one week wearing the activity monitors in school and the other week wearing the activity monitors on a ski vacation).
6. Intentional weight loss of more than 3 percent of body weight in the past two months.
7. Weight in excess of 300 lbs, because of the weight limits of the dual energy x-ray absorptiometry (DXA) scanners available at the NIH Clinical Center.
8. Inability to undergo MRI (e.g., volunteers with metal within their bodies including cardiac pacemakers, neural pacemakers, aneurysmal clips, shrapnel, ocular foreign bodies, cochlear implants, non-detachable electronic or electromechanical devices such as infusion pumps, nerve stimulators, bone growth stimulators, etc. that are contraindications).
9. Inability to tolerate study procedures at the screening visit.
7 Years
11 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA. 2004 Jun 16;291(23):2847-50. doi: 10.1001/jama.291.23.2847.
Ogden CL, Flegal KM, Carroll MD, Johnson CL. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA. 2002 Oct 9;288(14):1728-32. doi: 10.1001/jama.288.14.1728.
Sorof JM, Lai D, Turner J, Poffenbarger T, Portman RJ. Overweight, ethnicity, and the prevalence of hypertension in school-aged children. Pediatrics. 2004 Mar;113(3 Pt 1):475-82. doi: 10.1542/peds.113.3.475.
Manoli I, Sysol JR, Head PE, Epping MW, Gavrilova O, Crocker MK, Sloan JL, Koutsoukos SA, Wang C, Ktena YP, Mendelson S, Pass AR, Zerfas PM, Hoffmann V, Vernon HJ, Fletcher LA, Reynolds JC, Tsokos MG, Stratakis CA, Voss SD, Chen KY, Brown RJ, Hamosh A, Berry GT, Chen XS, Yanovski JA, Venditti CP. Lipodystrophy in methylmalonic acidemia associated with elevated FGF21 and abnormal methylmalonylation. JCI Insight. 2024 Feb 22;9(4):e174097. doi: 10.1172/jci.insight.174097.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
06-CH-0141
Identifier Type: -
Identifier Source: secondary_id
060141
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.